Healio’s recent stories in glaucoma include the de novo classification of an ocular pressure adjusting pump and promising results with timolol microdrops to lower IOP.
Check out these glaucoma articles and more below.
FDA grants de novo classification to Fysx ocular pressure adjusting pump
The FDA granted de novo classification to the Fysx ocular pressure adjusting pump for patients with normal-tension glaucoma or open-angle glaucoma with IOP of 21 mm Hg or less, according to a press release from Balance Ophthalmics. Read more.
Timolol microdrops appear as effective as conventional drops in